Antibodies floating on blue cell background – 3D illustration
getty
In less than a decade, bispecific antibodies have gone from scientific curiosity to frontline cancer therapeutics. These engineered proteins, capable of binding to two or more targets simultaneously, are reshaping immunotherapy….